Navigation Links
New antiperspirant in action - Botox does the difference

Wet palms, frequent changing of shirts - the result of excessive sweating - known as hyperhydrosis, is always a state of embarrasment. Botox, a purified form of Botulinum toxin type A, is now a new found solution for treating hyperhydrosis.

Prescription antiperspirants and some pills might help to overcome this situation, but not all people are benefited from this situation. Hence for these people injecting purified botulinum toxin into the skin does a greater relief for such condition.

Most sufferers "can find relief with prescription antiperspirants, special medicated powders, and other topical treatments," says Jim Baral, MD, who is a dermatologist at the American Dermatology Center in New York City and an assistant professor at the Mount Sinai School of Medicine. "There is even an oral drug called Robinul that can be used to stop excessive sweating, but it can have side effects like dry mouth. For a small number of patients, these options to not work. That's why we've started using Botox to treat people who don't respond to other medications."

It can stop sweat glands from over producing when nothing else works - when surgery is the only other option left.

"Botulinum toxin is a weakening agent, that, when injected, results in a chemical disconnection of the nerve, which is called chemodenervation," says Dr. Mitchell F. Brin, associate professor of neurology at Mount Sinai Medical Center in New York City, who has worked with the toxin. "In our studies, botulinum toxin therapy has been effective in 70 to 80% of patients treated."

The effect of the drug starts at around 3 to 4 days and the effect lasts for about 3 to 4 months.
'"/>




Page: 1

Related medicine news :

1. Distraction therapy found very effective in postoperative patients
2. ZYBAN, The smoking cessation drug marked for its adverse reactions
3. Diet Can Influence Allergic Skin Reactions
4. The phenomenon of sexual attraction
5. Influence of diet on allergic Reactions
6. Marriage does not have much impact on life satisfaction
7. Dyslexia may slow a drivers reaction time as much as moderate drinking!!
8. Lupin flour may cause peanut allergy like reactions
9. Herbal remedies can have harmful interaction when taken with drugs for rheumatic arthritis
10. Differing reactions to anti clotting drugs may be due to genetic variation.
11. Arsenic poisoning reactions can be traced to genes

Post Your Comments:
(Date:11/25/2009)... that grew out of a collaboration between UCLA eng... to the nearly 10 million Americans who suffer fro...as hardening of the arteries, peripheral arterial ...n which narrowed arteries reduce blood flow to the... vascular disease, heart attack and stroke, and it...
(Date:11/25/2009)... was too short to draw definite conclusions, exper...ay News) -- In diabetic patients with blocked coro...n outcomes at one year whether patients undergo by... researchers report. , Bypass surgery has been ...coronary artery disease. However, less invasive ap...
(Date:11/25/2009)...Evaluation and treatment clinics to resume Monday,...us) November 25, 2009 -- Centegra Health System is...vaccine shots at four Centegra Primary Care (CPC) ...ine has arrived. The clinics are at CPC sites in H...ll be open as follows: ,   From 4:30 t...
(Date:11/25/2009)... neurological symptoms, study finds , ,...al side effects are among the potential problems f...ho were treated with cisplatin-based chemotherapy,...409 Norwegian men treated for unilateral testicula...follow-up survey conducted from 1998 to 2002. ,...
(Date:11/25/2009)...ewswire/-- MISSIONSkincare ®isproudtosupportG...rtofGNC,sannualSt.Jude ThanksandGiving campaign,$1... SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Additi...r$10donationatcheckoutatoneoftheir5,000+retailloca...orSt.Judeduringtheir2009 ThanksandGiving campaign....
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...U.S. research team led by Professor Claudio Soto f...nfectious ‘prion’ proteins behind such diseases in...ps to detect the proteins that cause Mad Cow disea...ining the method to find prions in people who died...
...le who smoke are often the ones who make fewer vis...arts. This happens in spite of the fact that smoki...s than others.// The finding holds true rega...al of Health Behavior, analyzed data gathered duri...
...st research findings challenge the efficacy of soy...tion of soy protein found in tofu and other soybea... //In addition, isoflavones found in soy may reduc...uality, or their duration was too short to lead to...
...archers from Ohio State University College of Medi...fering from epilepsy and not responding well to ot...of a vagus nerve stimulator (VNS) with significant...than 12 to help control or reduce the seizures tha...
...seling the family at home can effectively encourag...ly true for children suffering from diseases. ...d found that home-based counseling could lead to h...nificant risk factors for heart attacks, strokes a...
...is an inherited disease in which the oxygen-carryi...ing the red cells a twisted (sickled) shape that c...nd other disabling and sometimes fatal complicatio... of Haematology. The current treatment for chil...
Other Medicine News:Health News:Blood Test To Detect Creutzfeldt-Jakob Disease/Mad Cow Disease 2Health News:Soy Not Such A Wonder For Health? 2Health News:Children With Epilepsy Can Be Treated With Nerve Stimulation 2Health News:Initiation Of New Study To Help Children With Sickle Cell Anaemia 2
(Date:11/25/2009)...,, BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Reg...lopmentofantithromboticaptamerswithactivecontrolag...illbepresentingatthePiperJaffray21stAnnualHealthCa...r.Mazzo,spresentationwillbegivenat1:10pm(EST)onTue...,spipelinewithemphasisontheleaddevelopmentprogram,...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker....einitscatalogue: ,, UnitedStatesDentalDevicesM....reportlinker.com/p0158733/United-States-Dental-De...,, UnitedStatesDentalDevicesMarketAnalysisandFo...essentialsourceforin-depthinformationanddatarelati...
(Date:11/25/2009)...,, UNIONCITY,Calif.,Nov.25/PRNewswire-FirstC...ompanymanufacturingpoint-of-carebloodanalysissyste...fexecutiveofficer,willpresentatthe21stAnnualPiperJ...09at2:00p.m.ET.TheconferencewillbeheldattheNewYork..., Abaxisdevelops,manufacturesandmarketsportableblo...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Insmed CEO Resigns Due to Health Concerns 12633 1Insmed CEO Resigns Due to Health Concerns 12633 2Insmed CEO Resigns Due to Health Concerns 12633 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 1Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 2Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 3Teens as Cardiologists in Training 3A Program Swaps Backpacks for Stethoscopes 48958 4Drug May Stem Slide Into Alzheimers for Some 48955 1Drug May Stem Slide Into Alzheimers for Some 48955 2
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
... is variably N-glycosylated. The variation account...tween 43 and 56 kDa. Insulin-like growth factor bi...inity but do not bind insulin. Of the six distinct...t this time, IGFBP-3 has been shown to be the majo...
...00 tests per year through automatic scheduling and...rocessing up to 4 assays on 4 plates simultaneousl... presentation of the results, are controlled by Wi...ube rack) and 256 (POS-ID Linear Rack) samples can...
Immunosimplicity® Is-ENA Screen Test Kit
IMMULITE 2000 IGFBP-3
Medicine Products: